Abiopharma

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Clinical trial NCT06704308: start date: 2026-05-01 → 2026-07-01.

Clinical trial NCT07548606: enrollment type: ESTIMATED → ACTUAL.

Clinical trial NCT05563220: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06780579: status: AVAILABLE → APPROVED_FOR_MARKETING.

Clinical trial NCT06161974: start date: 2025-03-01 → 2025-02-01.

Clinical trial NCT07141277 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-03-20 3. primary completion date: 2026-06-30 → 2026-03-20 4. enrollment: 4000 → 4060 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05113407 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-01 → 2027-09-01 3. primary completion date: 2025-12-01 → 2026-09-01 4. enrollment: 500 → 1000 participants

Form 8.3

Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach